Source link : https://www.newshealth.biz/health-news/first-drug-approved-for-familial-chylomicronemia-syndrome/
The FDA approved olezarsen (Tryngolza) as the first drug for adults with familial chylomicronemia syndrome, a rare genetic disorder that can cause triglyceride levels to reach the thousands. A first-in-class antisense oligonucleotide, olezarsen is indicated in conjunction with a low-fat diet. Approval was supported by the phase III Balance trial, which involved 66 patients with […]
Author : News Health
Publish date : 2024-12-20 19:06:38
Copyright for syndicated content belongs to the linked Source.